Brian Buntz is a journalist at various esteemed publications, including Medical Design & Outsourcing and MassDevice. He focuses on the intersection of artificial intelligence, healthcare technology, and applied sciences, covering topics such as AI platforms, biotechnology, and digital health. Brian's work has been featured in notable outlets like TED Conferences and Pharmaceutical Processing World.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Brian Buntz's articles primarily focus on the healthcare and pharmaceutical industry, with a strong emphasis on data-driven insights. His coverage suggests an interest in topics such as pharmaceutical innovation, M&A activity, emerging trends in drug approvals, and AI applications within healthcare.
Given his reliance on citing data and press releases, Brian may be interested in pitches that provide comprehensive data analysis or newsworthy findings related to pharmaceuticals, medical research advancements, or trends in healthcare technology. Additionally, he might be open to receiving press releases announcing significant developments within the healthcare and pharmaceutical sectors.
While Brian's geographic focus is not specified, his coverage appears to encompass global perspectives on the healthcare and pharmaceutical industry. Therefore, relevant pitches should consider international implications or broader industry trends rather than focusing solely on specific regional matters unless they have global significance.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Brian Buntz
OpenAI has launched ChatGPT for Academic Researchers, a program that offers 100,000 scientists, mathematicians and engineers free access to its frontier models. An initial cohort of 10,000 researchers will receive access this summer, with the program expanding through 2027. OpenAI says participant data will remain excluded from model training by default. The program joins ChatGPT…
By: Brian Buntz
Will AI soon be able to build AI? Maybe not quite as soon as some pundits have expected, based on a recent preprint from researchers at Princeton, Stanford, UC Berkeley, Johns Hopkins, the University of Toronto, Georgetown and the UK AI Security Institute. One important driver of the current AI wave is the expectation that…
By: Brian Buntz
R&D World announces the Special Recognition Green Tech winners for the 2026 R&D 100 Awards, honoring top global innovations in green tech and sustainability.
By: Brian Buntz
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
By: Brian Buntz
A potential AstraZeneca-BMS merger could create the world's largest drugmaker, potentially holding off Eli Lilly on revenue until about 2030.
By: Brian Buntz
The Special Recognition: Corporate Social Responsibility winners for the 2026 R&D 100 Awards have been announced by R&D World. Now in its 64th year, the global science and innovation competition drew entries from eight countries. A similarly global judging panel featured more than 50 industry professionals. Winners are listed below in order. Each listing includes…
By: Brian Buntz
After nearly four decades of developing laser diffraction particle analyzers, HORIBA is repositioning its Partica line around analyzing particle size and shape in a single workflow.
By: Brian Buntz
A neutron detector built around abundant lithium instead of scarce helium-3, a battery made of heated sand, and software that spots the faint electrical arcing that starts wildfires. The three winners of the 2026 R&D 100 Special Recognition: Market Disruptor award, announced today by R&D World.
By: Brian Buntz
The current AI wave is running into a type of sticker shock reminiscent of what happened when cloud computing went mainstream in the late 2000s and early 2010s. The pitch then was essentially: stop worrying about buying servers and running a data center for capacity you might not need. But it turns out that the…
The 2026 winners, announced today by R&D World, were selected from 149 finalists across six categories, 38 of them in Process/Prototyping.
